News for aTyr Pharma, Inc. (LIFE)

SAN DIEGO, Feb. 24, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. ( ATYR), a clinical stage biotechnology company engaged in the discovery and development of fir

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiat...

aTyr Pharma's stock surged on positive data for pulmonary sarcoidosis treatment, but cash balance risk keeps investors cautious. See why ATYR stock is a Hold.

Top Wall Street analysts initiated coverage on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiation...

SAN DIEGO, Dec. 12, 2024 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. ( ATYR) (”œaTyr” or the ”œCompany”), a clinical stage biotechnology company engaged in th

ATYR0101 interacts with LTBP-1 to induce myofibroblast apoptosis through a novel anti-fibrotic mechanism to reduce fibrosis and fibrotic markers in models of l

We recently published a list of 10 Best Multibagger Stocks To Buy Heading into 2025. In this article, we are going to take a look at where aTyr Pharma, Inc.

**media[467247]**

Revenue: Reported $0.353 million for the third quarter, significantly surpassing the analyst estimate of $0.02 million.Net Loss: Recorded a net loss of $17.26

aTyr Pharma has a pivotal year ahead with key readouts for Efzofitimod, potentially opening a huge market. Find out why ATYR stock is a Buy.

aTyr Pharma maintains $22 target on trial data optimism

Texas-based Beneficient (BENF), a technology-enabled financial services company is up over 55 percent in Friday's pre-market trading. The following are some of the other stocks making big moves in Friday's pre-market trading.

REDWOOD CITY, Calif., June 19, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused...

WAVE Life Sciences Ltd. (WVE), a preclinical biopharmaceutical company, has seen a significant increase in its stock price over the past three months. The compa

The dynamics of the amyotrophic lateral sclerosis market are anticipated to change in the coming years owing to the improvement in the diagnosis...

Vancouver, Kelowna, Delta, BC - February 10, 2023 (Investorideas.com Newswire) Investorideas.com, a global news source and expert investing resource, announces ...

Read Stock Analysts’ Upgrades for June 9th (APA, CAR, CVGW, ESCA, ESQ, ESSA, FATH, FCRD, FGBI, FGEN) at ETF Daily News

Global immunomodulators market is witnessing a considerable growth owing to increasing incidences of autoimmune diseases across the globe....

Read Investment Analysts’ Upgrades for May 11th (ADDYY, AHT, ARCT, ARTNA, ARWR, ASHTY, AZEK, BNCDY, CELH, CLB) at ETF Daily News